Intersect Ent Inc
NASDAQ:XENT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Intersect Ent Inc
Intersect Ent Inc
Accounts Payable
Intersect Ent Inc
Accounts Payable Peer Comparison
BDX
BSX
SYK
ABT
ISRG
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Intersect Ent Inc
NASDAQ:XENT
|
Accounts Payable
$9.2m
|
CAGR 3-Years
30%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accounts Payable
$5.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Payable
$921m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
|
Stryker Corp
NYSE:SYK
|
Accounts Payable
$1.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Payable
$4.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Payable
$194.4m
|
CAGR 3-Years
24%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
See Also
What is Intersect Ent Inc's Accounts Payable?
Accounts Payable
9.2m
USD
Based on the financial report for Mar 31, 2022, Intersect Ent Inc's Accounts Payable amounts to 9.2m USD.
What is Intersect Ent Inc's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
32%
Over the last year, the Accounts Payable growth was 33%. The average annual Accounts Payable growth rates for Intersect Ent Inc have been 30% over the past three years , 32% over the past five years .
You don't have any saved screeners yet
